Pulmonary Infection

2014. Pneumonia (NICE)

UK National Institute for Health and Clinical Excellence evidence based guidelines on Pneumonia; Diagnosis and management of community and hospital acquired pneumonia in adults.

2011. Guidelines for the management of adult lower respiratory tract Infections (ERS/ESCMID)

European Respiratory Society (ERS) and European Society of Clinical Microbiology and Infectious Diseases evidence-based recommendations for the most common management questions occurring in routine clinical practice in the management of adult patients with LRTI.

2011. The management of community acquired pneumonia in children (BTS)

British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011

2011. HIV-Associated Pulmonary Diseases (ATS)

An Official ATS Workshop Report: Emerging Issues and Current Controversies in HIV-Associated Pulmonary Diseases

2011. Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

2011. Community-Acquired Pneumonia in Children Older Than 3 Months of Age (PIDS/IDSA)

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

2010. Management of Pandemic Influenza A (H1N1) and other Influenza Viruses (WHO)

World Health Organisation (WHO) guidelines for the pharmacological management of pandemic Influenza A (H1N1) other Influenza Viruses: Recommendations

2009: Guidelines for the management of community acquired pneumonia in adults (BTS)

British Thoracic Society Guidelines for the management of community acquired pneumonia in adults

2009. Amantadine, oseltamivir and zanamivir for the treatment of influenza (NICE)

UK National Institute of Health and Clinical Excellence (NICE) recommends Oseltamivir and Zanamivir for the treatment of influenza in adults and children if influenza virus A or B is circulating, the person is in an ‘at-risk’ group, the person presents with an influenza-like illness and can start treatment within 48 hours (or within 36 hours for zanamivir treatment in children) of the onset of symptoms.

2009. Defining, treating and preventing hospital acquired pneumonia (ERS/ESCIMD/ESICM)

Defining, treating and preventing hospital acquired pneumonia: European perspective produced by the European Respiratory Society (ERS), European Society of Clinical Microbiology and Infectious Diseases and the European Society of Intensive Care Medicine.

2009. Clinical management of human infection with pandemic (H1N1) (WHO)

World Health Organisation revised guidance on the clinical management of human infection with pandemic (H1N1)